WORLDSymposium™ Announces Danilo A. Tagle, PhD, MS as Recipient of 2019 Roscoe O. Brady Award for Innovation and Accomplishment
Danilo A. Tagle, PhD, MS, is associate director for special initiatives at NCATS. He also recently served as acting director of the NCATS Office of Grants Management and Scientific Review and currently serves as executive secretary to the NCATS Advisory Council and Cures Acceleration Network Review Board. Prior to NCATS, Tagle was a program director for neurogenetics at the National Institute of Neurological Disorders and Stroke (NINDS), where he was involved in developing programs concerning genomics-based approaches for basic and translational research in inherited brain disorders.
Prior to joining NINDS in 2001, Tagle was an investigator and section head of molecular neurogenetics at the National Human Genome Research Institute and has been involved in the highly collaborative effort toward the positional cloning of genes for Huntington’s disease, ataxia-telangiectasia and Niemann-Pick disease type C. He has served on numerous committees and advisory boards, including the editorial boards of the journals Gene and the International Journal of Biotechnology.
Tagle leverages key resources and expertise through partnerships with stakeholders in biomedical research, including various government agencies, nonprofits, patient advocacy groups, industry organizations, pharmaceutical corporations and others in the private sector. He leads and provides scientific and programmatic oversight and coordination to the following trans-NIH programs:
- Extracellular RNA Communication
- NIH Microphysiological Systems (also known as the Tissue Chip for Drug Screening program)
- Regulatory Science
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
Tagle obtained his PhD in molecular biology and genetics from Wayne State University School of Medicine in 1990. He was an NIH National Research Service Award postdoctoral fellow in human genetics in the laboratory of Francis S. Collins, MD, PhD, at the University of Michigan. Tagle has authored more than 150 scientific publications and has garnered numerous awards and patents.
Dr. Tagle will receive the 2019 WORLDSymposium Roscoe O. Brady Award for Innovation and Accomplishment on Tuesday, February 5, 2019 at 7:30 AM.
About the WORLDSymposium™ Roscoe O. Brady Award for Innovation and Accomplishment
Each year, WORLDSymposium recognizes one individual for innovation and accomplishment in the field of lysosomal disease research and therapy. This award has been renamed the Roscoe O. Brady Award for Innovation and Accomplishment to honor one of the early pioneers in lysosomal research, Roscoe O. Brady, MD, who was a beloved mentor to many currently working in the field. Dr. Brady passed away in 2016, and WORLDSymposium has renamed the annual Innovation and Accomplishment Award to honor his achievements.
The award will be presented at the WORLDSymposium 2019 opening session on Tuesday, February 5, 2019 at 7:30 AM.
The award is presented annually to recognize substantial contributions to lysosomal disease research and therapy. The recipient is presented with an engraved award and is recognized at the WORLDSymposium scientific meeting held annually in February. The award winner is also invited to present a 30-minute address as the opening speaker at WORLDSymposium, and an announcement of the award recipient is included in the February special lysosomes issue of Molecular Genetics and Metabolism. (This award is given on a yearly basis, but can be omitted in any given year at the discretion of the Planning Committee.) Nominations are solicited annually from members of the lysosomal disease community, planning committee members and attendees of WORLDSymposium.
Past Award Recipients:
2004 William Krivit, MD, PhD
2006 Henri A. Termeer
2008 Roscoe O. Brady, MD
2009 Elizabeth F. Neufeld, PhD
2010 William S. Sly, MD
2011 Steven U. Walkley, PhD
2012 John J. Hopwood, PhD
2013 Robert J. Desnick, PhD, MD
2014 Gregory A. Grabowski, MD
2015 Stephen C. Groft, PharmD
2016 Emil D. Kakkis, MD, PhD
2017 Konrad Sandhoff, PhD
2018 Mark E. Haskins, VMD, PhD